Cardiac Drug Development Guide /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Pugsley, Michael K. (Editor )
Formato: eBook
Lenguaje:English
Publicado: Totowa, NJ : Humana Press : Imprint: Humana, 2003.
Edición:1st ed. 2003.
Colección:Methods in Pharmacology and Toxicology,
Materias:
LEADER 02208nam a22002775i 4500
001 000279614
005 20220124120245.0
007 cr nn 008mamaa
008 100301s2003 xxu| s |||| 0|eng d
020 |a 9781592594047 
024 7 |a 10.1385/1592594042  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Cardiac Drug Development Guide /  |c edited by Michael K. Pugsley. 
250 |a 1st ed. 2003. 
260 # # |a Totowa, NJ :  |b Humana Press :  |b Imprint: Humana,  |c 2003. 
300 |a X, 431 p. :  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Methods in Pharmacology and Toxicology, 
505 0 |a Cardiac Drug Development -- Novel Molecular Targets for Cardiac Drug Development -- The Role of Cardiac Pacemaker Currents in Antiarrhythmic Drug Discovery -- Oxygen Free Radicals in Heart Disease -- Mitogen-Activated Protein Kinases-Mediated Signaling in Cardiac Pathology -- Development of Anti-Inflammatory Drugs for Cardiovascular Disease -- Development and Use of Platelet Glycoprotein Antagonists in Heart Disease -- The Sodium-Hydrogen Exchange System in the Heart -- Nitric Oxide and Cardiac Ischemia -- Functional Endpoints Evaluating Cardiac Drug Activity -- Ionic Mechanisms of Atrial Fibrillation -- Targeting Ischemic Ventricular Arrhythmias -- Biochemical Mediators of Ventricular Arrhythmias in Ischemic Heart Disease -- Heterologous Expression Systems and Screening Technologies in Ion Channel Drug Discovery -- Molecular Diversity of Ion Channels in the Mouse Heart -- Delayed Protection of the Myocardium -- Clinical Aspects in Cardiac Drug Development -- Cardiac Troponin Testing for Detection of Myocardial Infarction -- A Genetic Basis for Cardiac Arrhythmias -- Myocardial Adenoviral Vector Delivery for Cardiovascular Gene Therapy -- The Role of Pharmacometrics in Cardiovascular Drug Development -- Gender Differences in Heart Failure -- Angiogenesis Therapies for Coronary Artery Disease. 
650 0 |a Pharmacy. 
650 1 4 |a Pharmacy. 
700 1 |a Pugsley, Michael K.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks